Biotech Stocks

biotech stocks Did Alexion Jump the Shark With Its Synageva Bid? (ALXN, GEVA)
Source: ©iStock.com/AlexRaths
Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

Recent Articles

Did Alexion Jump the Shark With Its Synageva Bid? (ALXN, GEVA)

While ALXN seems to have overpaid for GEVA on the surface. However, investors can expect to see the benefits over the long-term. More 

3 Potent Biotech Stocks That Could Pop on Earnings

Harness the volatility of the biotechnology sector by letting stats tell the story. Bank on these three biotech stocks ahead of earnings. More 

10 Stocks With 3,000%-Plus Returns (And What You Can Learn From Them)

The list of top 10 stocks of the last decade is heavy on biotechs, but also includes beverages, media and a specialty chemicals company. More 

Are Large-Cap Biotech Stocks in a Bubble?

Biotech stocks have outpaced the rest of the market by a huge margin, but it takes more than gaudy performance numbers to create a bubble. More 

MARCH MADNESS: Amgen (AMGN) vs. CVS Health (CVS)

Amgen (AMGN) and CVS Health Corp (CVS) find themselves on opposite sides when it comes to pricing for the latest drugs. More 

4 (More) Biotech Stocks to Buy

Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration. More 

5 Biotech Stocks With Explosive Drug Pipelines

For many biotech stocks, drug pipelines -- not trailing results -- determine their actual value. That's good news for investors in these 5 biotechs. More 

Gilead Stock: This Beatdown Was Way Overdone (GILD)

Gilead Sciences, Inc. (GILD) was driven down by news from AbbVie, but the market may have overreacted and turned Gilead stock into a value buy. More 

2 New Funds Add a New Twist to Biotech Stocks

Calling all fans and followers of breakthrough biotech stocks! Stop searching for the next big winner and just own one of these new biotech ETFs instead. More 

3 Ways to Play the Bounce in Biotech Stocks

Biotech stocks delivered big this year for investors pursuing an aggressive growth strategy, driven by exciting new treatments for dread diseases like cancer, multiple sclerosis, hepatitis and HIV. And some have room to run in 2015. More